Carol Gallagher
Fortune : 289 112 $ au 30/06/2026
Fortune : 289 112 $ au 30/06/2026
Carol Giltner Gallagher currently works at TRex Bio, Inc., as Executive Chairman, Millendo Therapeutics US, Inc., as Director from 2012, PMV Pharmaceuticals, Inc., as Independent Director from 2022, and various other companies.
Dr. Gallagher also formerly worked at Metastatix, Inc., as President & Chief Executive Officer from 2007 to 2008, Calistoga Pharmaceuticals, Inc., as President & Chief Executive Officer from 2010 to 2011, eFFECTOR Therapeutics Operations, Inc., as Chairman from 2012 to 2014, and various other companies.
Dr. Gallagher received her undergraduate degree and doctorate degree from the University of Kentucky College of Pharmacy.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/03/2026 | 25 184 ( 0,28 % ) | 289 112 $ | 30/06/2026 | |
| 04/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 03/11/2022 |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Directeur/Membre du Conseil | - |
Xoc Pharmaceuticals, Inc.
Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Directeur/Membre du Conseil | 01/10/2018 |
Trex Bio, Inc.
Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Président | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Directeur/Membre du Conseil | - |
Certara Holdings, Inc.
Certara Holdings, Inc. Packaged SoftwareTechnology Services Develops software for clinical pharmacology | Directeur/Membre du Conseil | - |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Directeur/Membre du Conseil | 01/09/2012 |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Consultant / Advisor | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Président | 09/09/2024 |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 39 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Metastatix, Inc.
Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Develops small moleclue drugs | Health Technology |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Sharp HealthCare
Sharp HealthCare Hospital/Nursing ManagementHealth Services Operates acute care and specialty hospitals | Health Services |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Health Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
University of Kentucky College of Pharmacy
University of Kentucky College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Metacrine, Inc.
Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
ChromaCode, Inc.
ChromaCode, Inc. Packaged SoftwareTechnology Services Develops software and manufactures laboratory instruments | Technology Services |
Xoc Pharmaceuticals, Inc.
Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Commercial Services |
Qpex Biopharma, Inc.
Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company | Health Technology |
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance Operates as a venture capital firm | Finance |
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Trex Bio, Inc.
Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Certara, Inc.
Certara, Inc. Packaged SoftwareTechnology Services Develops bio simulation software and technology to transform traditional drug discovery and development | Technology Services |
Frazier Lifesciences Acquisition Corp.
Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Certara Holdings, Inc.
Certara Holdings, Inc. Packaged SoftwareTechnology Services Develops software for clinical pharmacology | Technology Services |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national